Effect of α1-adrenergic receptors in cardiac pathophysiology-Reference-Cited by-同舟云学术

Effect of α1-adrenergic receptors in cardiac pathophysiology

Published:2006-11 Issue:5 Volume:152 Page:842-850
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Shannon Richard,Chaudhry Mohammad

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference59 articles.

1. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA cooperative studies group;Loeb;Circulation,1993

2. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial;Poole-Wilson;Lancet,2003

3. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group;ALLHAT Collaborative Research Group;JAMA,2000

4. Transgenic studies of alpha(1)–adrenergic receptor subtype function;Tanoue;Life Sci,2002

5. Cardiovascular alpha1-adrenoceptor subtypes: functions and signaling;Varma;Can J Physiol Pharmacol,2000

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexmedetomidine in Palliative Care: A Versatile New Weapon Against Delirium and Pain—Systematic Review;Journal of Palliative Medicine;2024-05-21

2. Neurohormones in cardiac remodeling and function;Cellular, Molecular, and Environmental Contribution in Cardiac Remodeling;2024

3. The Subtype Selectivity in Search of Potent Hypotensive Agents among 5,5-Dimethylhydantoin Derived α1-Adrenoceptors Antagonists;International Journal of Molecular Sciences;2023-11-22

4. Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome;Metabolites;2023-11-03

5. α-Blocker Use in Hemodialysis: The Japan Dialysis Outcomes and Practice Patterns Study;Kidney Medicine;2023-09